Can a simple blood test predict bone disease in cystic fibrosis?
NCT ID NCT03492567
First seen Nov 20, 2025 · Last updated May 12, 2026 · Updated 22 times
Summary
This study aims to find risk factors for developing osteoporosis in people with cystic fibrosis. Researchers will take a blood sample and study monocytes, which can turn into osteoclasts—cells that break down bone. They will also test whether CFTR modulators affect these bone cells.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cochin Hospital
Paris, Paris, 75014, France
Conditions
Explore the condition pages connected to this study.